In the ferret, 5-HT3 receptor antagonists are effective in controlling emesis produced by cytotoxic agents or radiation. To investigate the possibility that substance P has a role, as well as 5-HT, in the emetic reflex pathway, we have examined the anti-emetic effects of a NK1 receptor antagonist (racemic CP-99,994) in the ferret. Racemic CP-99,994 was effective against a range of emetogens, comprising cytotoxic drugs, radiation, morphine, ipecacuanha and copper sulphate
of ferret lower esophageal sphincter to 5hydroxytryptamine: pathways and receptor subtypes. Am. J. P...
1. Release of substance P in the dorsal horn is considered a primary event in the perception of pain...
In this report the in vitro and in vivo pharmacological and pharmacokinetic profile of ()-(S)-N-(-et...
1. Following our earlier observations that the tachykinin NK1 receptor antagonist CP-99,994 is an ef...
The involvement of 5-hydroxytryptamine (5-HT) 5-HT3 receptors in the mechanisms of severe emesis ev...
In ferrets, the selective 5-hydroxytryptamine (5-HT) 5-HT3 receptor antagonist BRL 43694 given as a ...
MDL 72222, the selective 5-hydroxytryptamine (5-HT) M-receptor antagonist, prevented or reduced cisp...
Diverse transmitter systems (e.g. acetylcholine, dopamine, endocannabinoids, endorphins, glutamate, ...
This study investigates the role of substance P and NK-1 receptors in an animal model of neuropathi...
Repeated oesophageal acidification is a definitive feature of gastro-oesophageal reflux disease, whi...
The antiemetic effects of a novel serotonin3 receptor antagonist, DAT-582 {(6RH-)-N-[1-methyl-4-(3-m...
The effects of synthetic tachykinin receptor agonists on mucus secretion by ferret trachea was deter...
The neurokinin 1 receptor (NK-1R) is the main receptor for the tachykinin family of peptides. Substa...
The introduction of 5-HT3 antagonists, such as ondansetron, as antiemetic agents has transformed the...
Cyclophosphamide (177 mg/kg, IV; n = 8) produced it biphasic emetic response in the ferret with a me...
of ferret lower esophageal sphincter to 5hydroxytryptamine: pathways and receptor subtypes. Am. J. P...
1. Release of substance P in the dorsal horn is considered a primary event in the perception of pain...
In this report the in vitro and in vivo pharmacological and pharmacokinetic profile of ()-(S)-N-(-et...
1. Following our earlier observations that the tachykinin NK1 receptor antagonist CP-99,994 is an ef...
The involvement of 5-hydroxytryptamine (5-HT) 5-HT3 receptors in the mechanisms of severe emesis ev...
In ferrets, the selective 5-hydroxytryptamine (5-HT) 5-HT3 receptor antagonist BRL 43694 given as a ...
MDL 72222, the selective 5-hydroxytryptamine (5-HT) M-receptor antagonist, prevented or reduced cisp...
Diverse transmitter systems (e.g. acetylcholine, dopamine, endocannabinoids, endorphins, glutamate, ...
This study investigates the role of substance P and NK-1 receptors in an animal model of neuropathi...
Repeated oesophageal acidification is a definitive feature of gastro-oesophageal reflux disease, whi...
The antiemetic effects of a novel serotonin3 receptor antagonist, DAT-582 {(6RH-)-N-[1-methyl-4-(3-m...
The effects of synthetic tachykinin receptor agonists on mucus secretion by ferret trachea was deter...
The neurokinin 1 receptor (NK-1R) is the main receptor for the tachykinin family of peptides. Substa...
The introduction of 5-HT3 antagonists, such as ondansetron, as antiemetic agents has transformed the...
Cyclophosphamide (177 mg/kg, IV; n = 8) produced it biphasic emetic response in the ferret with a me...
of ferret lower esophageal sphincter to 5hydroxytryptamine: pathways and receptor subtypes. Am. J. P...
1. Release of substance P in the dorsal horn is considered a primary event in the perception of pain...
In this report the in vitro and in vivo pharmacological and pharmacokinetic profile of ()-(S)-N-(-et...